Displaying items by tag: coronavirus vaccine

Safety trials are underway for a Cambridge-led vaccine that could be used as a booster targeting Covid variants which threaten future coronavirus pandemics. The first volunteer received the vaccine on 14 December through a needle-free ‘injection’ - a blast of air that delivers it into the skin. This offers a possible future alternative to people who fear needle-based jabs. If it is successful it could be scaled up and manufactured as a powder to boost global vaccination efforts, particularly in low and middle-income countries. As new variants emerge there is a need for newer technologies. It’s vital that science continues to develop new generation vaccines. Pray for this new trial to lead the way for vaccines that will prime the immune system to respond with broader, stronger protection. The vaccine trial will follow up volunteers for about a year to ensure it is safe.